Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

294 works between 1988 and 2024

181 - 200 of 294 works

2014

Conference Publication

Diagnostic criteria for ductal adenocarcinoma of the prostate. Interobserver variability among 20 expert uropathologists

Seipel, A. H., Delahunt, B., Samaratunga, H., Amin, M., Barton, J., Berney, D. M., Billis, A., Cheng, L., Comperat, E., Evans, A., Fine, S. W., Grignon, D., Humphrey, P. A., Magi-Galluzzi, C., Montironi, R., Sesterhenn, I., Srigley, J. R., Trpkov, K., van der Kwast, T., Varma, M., Zhou, M., Ahmad, A., Moss, S. and Egevad, L. (2014). Diagnostic criteria for ductal adenocarcinoma of the prostate. Interobserver variability among 20 expert uropathologists. 103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), San Diego, United States, Mar 01-07, 2014. London United Kingdom: Nature Publishing Group. doi: 10.1038/labinvest.2014.23

Diagnostic criteria for ductal adenocarcinoma of the prostate. Interobserver variability among 20 expert uropathologists

2014

Journal Article

Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?

Ng, Keng Lim, Rajandram, Retnagowri, Morais, Christudas, Yap, Ning Yi, Samaratunga, Hema, Gobe, Glenda C. and Wood, Simon T. (2014). Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?. Journal of Clinical Pathology, 67 (2), 97-104. doi: 10.1136/jclinpath-2013-201895

Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?

2014

Journal Article

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

Samaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Perry-Keene, Joanna, Lamb, David S., Srigley, John R., Egevad, Lars and Nacey, John N. (2014). Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men. Pathology, 46 (1), 11-14. doi: 10.1097/PAT.0000000000000044

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

2014

Book Chapter

Prostate cancer part one: detection

Gardiner, R. A., Chambers, S. K., Williams, S. G., Yaxley, J., Samaratunga, H. and Frydenberg, M. (2014). Prostate cancer part one: detection. Endotext. (pp. ---) Massachusetts, United States of America: MDTEXT.COM.

Prostate cancer part one: detection

2014

Conference Publication

MR guided prostate biopsy: our initial experience

Desai, D., Herrmann, R., Samaratunga, H., Kennedy, D., Clarke, R. and Swindle, P. (2014). MR guided prostate biopsy: our initial experience. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane Australia, Mar 16-19, 2014. West Sussex United Kingdom: Wiley-Blackwell Publishing.

MR guided prostate biopsy: our initial experience

2014

Conference Publication

Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and risk category? A comparative analysis

Scott, S., Chabert, C., Samaratunga, H., Breckenridge, M. and Gianduzzo, T. (2014). Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and risk category? A comparative analysis. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and risk category? A comparative analysis

2014

Conference Publication

Prostate needle biopsy is predictive of neurovascular bundle involvement in radical prostatectomy

Samaratunga, H., Yaxley, J. and Delahunt, B. (2014). Prostate needle biopsy is predictive of neurovascular bundle involvement in radical prostatectomy. 103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), San Diego United States, Mar 01-07, 2014. London United Kingdom: Nature Publishing Group. doi: 10.1038/labinvest.2014.23

Prostate needle biopsy is predictive of neurovascular bundle involvement in radical prostatectomy

2013

Journal Article

Premalignant lesions of the urinary bladder

Samaratunga, Hemamali, Martignoni, Guido, Egevad, Lars and Delahunt, Brett (2013). Premalignant lesions of the urinary bladder. Pathology, 45 (3), 243-250. doi: 10.1097/PAT.0b013e32835f6169

Premalignant lesions of the urinary bladder

2013

Book Chapter

Pathology of the renal pelvis and ureter

Delahunt, Brett and Samaratunga, Hemamali (2013). Pathology of the renal pelvis and ureter. Urological pathology. (pp. 261-294) London, United Kingdom: Wolters Kluwer Health Adis (ESP).

Pathology of the renal pelvis and ureter

2013

Journal Article

Handling and staging of renal cell carcinoma the international society of urological pathology consensus (ISUP) conference recommendations

Trpkov, Kiril, Grignon, David J., Bonsib, Stephen M., Amin, Mahul B., Billis, Athanase, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Tamboli, Pheroze, Delahunt, Brett, Egevad, Lars, Montironi, Rodolfo, Srigley, John R. and the ISUP Renal Tumor Panel (2013). Handling and staging of renal cell carcinoma the international society of urological pathology consensus (ISUP) conference recommendations. American Journal of Surgical Pathology, 37 (10), 1505-1517. doi: 10.1097/PAS.0b013e31829a85d0

Handling and staging of renal cell carcinoma the international society of urological pathology consensus (ISUP) conference recommendations

2012

Journal Article

Alpha-fetoprotein-producing Carcinoma of the Renal Pelvis Exhibiting Hepatoid and Urothelial Differentiation

Samaratunga, Hemamali, Samaratunga, Dinithi, Dunglison, Nigel, Perry-Keene, Joanna, Nicklin, James and Delahunt, Brett (2012). Alpha-fetoprotein-producing Carcinoma of the Renal Pelvis Exhibiting Hepatoid and Urothelial Differentiation. Anticancer Research, 32 (11), 4987-4991.

Alpha-fetoprotein-producing Carcinoma of the Renal Pelvis Exhibiting Hepatoid and Urothelial Differentiation

2012

Journal Article

Genetic Association of the KLK4 Locus with Risk of Prostate Cancer

Lose, Felicity, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Spurdle, Amanda B., Batra, Jyotsna, Clements, Judith A., the Australian Prostate Cancer BioResource and Samaratunga, Hema (2012). Genetic Association of the KLK4 Locus with Risk of Prostate Cancer. PLoS One, 7 (9) e44520, e44520-1-e44520-14. doi: 10.1371/journal.pone.0044520

Genetic Association of the KLK4 Locus with Risk of Prostate Cancer

2012

Journal Article

Evidence for steroidogenic potential in human prostate cell lines and tissues

Bennett, Nigel C., Hooper, John D., Lambie, Duncan, Lee, Cheok S., Yang, Tao, Vesey, David A., Samaratunga, Hemamali, Johnson, David W. and Gobe, Glenda C. (2012). Evidence for steroidogenic potential in human prostate cell lines and tissues. American Journal of Pathology, 181 (3), 1078-1087. doi: 10.1016/j.ajpath.2012.06.009

Evidence for steroidogenic potential in human prostate cell lines and tissues

2012

Journal Article

Recently described and unusual variants of urothelial carcinoma of the urinary bladder

Samaratunga, Hemamali and Delahunt, Brett (2012). Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Pathology, 44 (5), 407-418. doi: 10.1097/PAT.0b013e3283560172

Recently described and unusual variants of urothelial carcinoma of the urinary bladder

2012

Conference Publication

Molecular and metabonomic ejaculate profiling enables prostate cancer detection

Roberts, M., Teng, L., Buck, M., Schirra, H., Hancock, J., Clarke, R., Samaratunga, H., Zenzmaier, C., Lavin, M. and Gardiner, R. (2012). Molecular and metabonomic ejaculate profiling enables prostate cancer detection. 65th Annual Scientific Meeting on Urological Society of Australia and New Zealand, Darwin, NT, Australia, 21-24 April 2012. Oxford England U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2012.11074.x

Molecular and metabonomic ejaculate profiling enables prostate cancer detection

2012

Journal Article

Gleason grading: Past, present and future

Delahunt, Brett, Miller, Rose J., Srigley, John R., Evans, Andrew J. and Samaratunga, Hemamali (2012). Gleason grading: Past, present and future. Histopathology, 60 (1), 75-86. doi: 10.1111/j.1365-2559.2011.04003.x

Gleason grading: Past, present and future

2011

Journal Article

Ductal adenocarcinoma of the prostate-reply

Samaratunga, Hemamali, Yaxley, John and Delahunt, Brett (2011). Ductal adenocarcinoma of the prostate-reply. Human Pathology, 42 (4), 606-607. doi: 10.1016/j.humpath.2010.07.026

Ductal adenocarcinoma of the prostate-reply

2011

Conference Publication

Total Submission of Pelvic Lymphadenectomies Performed at Radical Prostatectomy Increases Lymph Node Yields and Detection of Microscopic Metastases

Perry-Keene, J. L., Samaratunga, H., Vyas, V. and Delahunt, B. (2011). Total Submission of Pelvic Lymphadenectomies Performed at Radical Prostatectomy Increases Lymph Node Yields and Detection of Microscopic Metastases. 100th Annual Meeting of the United States and Canadian-Academy-of-Pathology, San Antonio Tx, Feb 26-Mar 04, 2011. NEW YORK: NATURE PUBLISHING GROUP.

Total Submission of Pelvic Lymphadenectomies Performed at Radical Prostatectomy Increases Lymph Node Yields and Detection of Microscopic Metastases

2011

Journal Article

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens

Kench, James G., Clouston, David R., Delprado, Warick, Eade, Thomas, Ellis, Dllis, Horvath, Lisa G., Samaratunga, Hemamali, Stahl, Jurgen, Stapleton, Alan M. F., Egevad, Lars, Srigley, John R. and Delahunt, Brett (2011). Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology, 43 (5), 410-419. doi: 10.1097/PAT.0b013e328348a6b3

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens

2011

Conference Publication

Multiple markers in prostate cancer detection from ejaculate

Gardiner, R. A., Teng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H. J., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G. and Lavin, M. F. (2011). Multiple markers in prostate cancer detection from ejaculate. 64th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Christchurch, New Zealand, 21-24 February 2011. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2011.9997.x

Multiple markers in prostate cancer detection from ejaculate

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au